BT4ChildLC, the research program against childhood liver cancer
BT4ChildLC, the research program against childhood liver cancer
BT4ChildLC is a research program aimed at identifying predictive biomarkers and new therapies to fight childhood and adolescent liver cancer more effectively. About Pediatric Liver Cancer In children, malignant tumors originating in the liver are rare, accounting for 1% of pediatric cancers. In 90% of cases, these are either hepatoblastomas (HB, 2/3) or hepatocarcinomas (HCC, […]
HEM-iSMART, a clinical trial for better treatment of leukemia and lymphoma
HEM-iSMART, a clinical trial for better treatment of leukemia and lymphoma
HEM-iSMART is an international clinical trial, co-funded by Imagine for Margo, aimed at improving the treatment of refractory pediatric malignant leukemia and lymphoma. Childhood Leukemias Leukemia in children is similar to that in adults but can have certain peculiarities. Acute leukemia is a type of cancer characterized by the spread of cancerous cells originating from […]
NEWTargets, a research program to find a better cure for Ewing’s sarcoma
NEWTargets, a research program to find a better cure for Ewing’s sarcoma
NEWTargets is a research program aimed at using immunotherapy to target neoproteins specific to Ewing’s sarcoma, in order to cure children and adolescents suffering from this type of disease more effectively. Childhood Sarcomas Ewing sarcoma is the second most common malignant bone tumor after osteosarcoma in adolescents and young adults. Ewing sarcoma affects approximately 80 […]
PG-AML, the personalized treatment program for children with myeloid leukemia
PG-AML, the personalized treatment program for children with myeloid leukemia
PG-AML is a genomic analysis research program designed to personalize treatment for children with myeloid leukemia. Acute Myeloid Leukemia in Children Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. AML is the second most common leukemia in children after acute lymphoblastic leukemia (ALL). Approximately 80 children in France are diagnosed […]
Neuroblastoma relapse prevention research program
Neuroblastoma relapse prevention research program
Research program led by Prof. Rogier Versteeg on combinatorial therapy to prevent fatal relapses in pediatric neuroblastoma. Neuroblastomas in Children A neuroblastoma is an extracerebral malignant tumor that develops from primitive nerve cells, called neuroblasts, which normally form the nerve cells of the body. This type of solid tumor is one of the most common […]
ATG4TALL: a preclinical platform to fight leukemia
ATG4TALL: a preclinical platform to fight leukemia
ATG4TALL is a preclinical platform for testing new drugs for T-cell acute lymphoblastic leukemia. Childhood Leukemia Childhood leukemia is similar to adult leukemia but can present certain peculiarities. Acute leukemia is a type of cancer characterized by the spread of cancerous cells from bone marrow stem cells. These cells multiply chaotically, invade the bone marrow, […]
BioESMART- IGF-1R/HER3 the new AcSé-ESMART treatment arm
BioESMART- IGF-1R/HER3 the new AcSé-ESMART treatment arm
New AcSé-ESMART treatment arm: Testing a novel bispecific antibody targeting IGF-R1 & HER3 in Ewing’s sarcoma and other pediatric cancers Childhood Sarcomas Ewing sarcoma is the second most common malignant bone tumor after osteosarcoma among adolescents and young adults. Ewing sarcoma affects approximately 80 to 100 new patients per year in France. The majority of […]
What is a sarcoma?
What is a sarcoma?
Sarcomas are malignant tumors that develop from the body’s supporting tissues or “soft tissues” such as muscles, adipose tissue, cartilage, blood vessels or lymphatics, nerves, or bones. The type of sarcoma depends on the type of cells from which it originated. Sarcomas can be classified into three major categories: Soft tissue sarcomas Visceral sarcomas Bone […]
